Kyushu University Academic Staff Educational and Research Activities Database
Search by Keyword How ro search
Keyword
Search Criteria
 
Detailed Search

Researcher information (To researchers) Need Help? How to update
Hideaki Yahata Last modified date：2023.07.03

Associate Professor / Obstetrics & Gynecology
Department of Clinical Medicine
Faculty of Medical Sciences


Graduate School
Department of Reproductive and Developmental Medicine
Graduate School of Medical Sciences
Department of Reproductive and Developmental Medicine
Graduate School of Medical Sciences
Administration Post
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other


E-Mail　*Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
Homepage
https://kyushu-u.pure.elsevier.com/en/persons/hideaki-yahata
　Reseacher Profiling Tool　Kyushu University Pure
Phone
092-642-5395
Fax
092-642-5414
Academic Degree
MD-phD
Country of degree conferring institution (Overseas)
No
Field of Specialization
Gynecological Oncology
Total Priod of education and research career in the foreign country
01years00months
Outline Activities
Gynecologic Oncology
Research
Research Interests
  • Long-term follow up after sentinel node navigation surgery for early stage cervical cancer
    keyword : sentinel node, cervical cancer, navigation surgery
    2021.01～2021.07.
  • development of diagnosis of sentinel lymph node using new tracer
    keyword : new tracer, sentinel
    2019.01.
  • new method of vaginal suture
    keyword : vaginal suture
    2019.01.
  • Re-assesment of vessel permeation and stromal invasion for risk classification of cervical cancer
    keyword : cervical cancer risk classification
    2018.06～2018.06.
  • Clinical trial　of sentinel lymph node navigation surgery with intraoperative diagnosis in cervical cancer
    keyword : cervical cancer SNNS
    2015.07～2018.03.
  • The study of sexual QOL assesment after trachelectomy in young cervical cancer patient
    keyword : QOL　cervical cancer tracelectomy
    2014.05～2015.03.
  • Aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy: a multicenter, placebo-controlled, double-blind, randomized study in Japanese gynecologic patients receiving paclitaxel and carboplatin.
    keyword : CINV MEC regimen
    2014.04～2015.03.
  • The study of hypersensitive reaction caused by paclitaxel
    keyword : paclitaxel hypersensitivity
    2012.05～2013.12.
  • Clinical trial for gynecologic malignancy
    Clinical research for hypersensitivity reaction in administration of paclitaxel
    Sentinel node navigation for cervical cancer
    keyword : Gynecological Oncology
    2009.04～2011.03.
Academic Activities
Papers
 Show All Papers >>
1. Yahata H, Kato K, Shimokawa M, Kawamura K, Shimono N, Kawana K, Okamoto A, Aoki D, Kimura T. , Study of the effects of in-person attendance at academic conferences on the health of the attendees under COVID-19 pandemic.
, J Obstet Gynaecol Res, 49, 4, 1083-1089, 2023.04.
2. Asanoma K, Yahata H, Okugawa K, Ohgami T, Yasunaga M, Kodama K, Onoyama I, Kenjo H, Shimokawa M, Kato K. , Impact of obesity on robotic-assisted surgery in patients with stage IA endometrial cancer and a low risk of recurrence: an institutional study.
, J Obstet Gynaecol Res., 10.1111/jog.15434., 2022.09.
3. Yahata H, Kodama K, Okugawa K, Hachisuga K, Yasutake N, Maenohara S, Yagi H, Yasunaga M, Ohgami T, Onoyama I, Asanoma K, Sonoda K, Kobayashi H, Baba S, Ishigami K, Ohishi Y, Oda Y, Kato K. , Long-term follow up after sentinel node biopsy alone for early-stage cervical cancer
, Gynecol Oncol, 165, 1, 149-154, 2022.04.
4. Yasunaga M, Yahata H, Okugawa K, Kodama K, Yagi H, Ohgami T, Onoyama I, Asanoma K, Kato K. , Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases.
, Int J Clin Oncol, 2021.03.
5. Kodama K, Yahata H, Okugawa K, Tomonobe H, Yoshida S, Yasutake N, Yagi H, Ohgami T, Yasunaga M, Onoyama I, Asanoma K, Hori E, Shimokawa M, Kato K. , Prognostic outcomes and risk factors for recurrence after laser vaporization for cervical intraepithelial neoplasia: a single-center retrospective study.
, Int J Clin Oncol, 2021.02.
6. Yamaguchi S, Yahata H, Okugawa K, Kodama K, Yagi H, Ohgami T, Yasunaga M, Onoyama I, Asanoma K, Kato K. , Hypersensitivity reaction to PEGylated liposomal doxorubicin administration for Mullerian carcinoma in Japanese women.
, J Obstet Gynaecol Res, 2021.02.
7. Yahata H, Sonoda K, Inoue S, Yasutake N, Kodama K, Yagi H, Yasunaga M, Ohgami T, Onoyama I, Kaneki E, Okugawa K, Asanoma K, Kato K. , Is adjuvant therapy necessary for patients with intermediate-risk cervical cancer after open radical hysterectomy?
, Oncology, 2020.07.
8. Yahata H, Sonoda K, Okugawa K, Yagi H, Yasunaga M, Ohgami T, Onoyama I, Kaneki E, Asanoma K, Kato K. , Survey of the desire to have children and engage in sexual activity after trachelectomy among young Japanese women with early-stage cervical cancer.
, J Obstet Gynaecol Res, 2019.10.
9. Yahata H, Kobayashi H, Sonoda K, Kodama K, Yagi H, Yasunaga M, Ohgami T, Onoyama I, Kaneki E, Okugawa K, Baba S, Isoda T, Ohishi Y, Oda Y, Kato K., Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer., Int J Clin Oncol., 2018.12.
10. Hideaki Yahata, Kenzo Sonoda, Yasunaga Masafumi, Tatsuhiro Ogami, Kaneki Eisuke, Kawano Yoshiaki, Okugawa Kaoru, Tsunehisa Kaku, Kato K, Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1)., Asia Pac J Clin Oncol., 2017.04, Aim: To investigate the surgical outcome of FIGO stage IA1 cervical adenocarcinoma. Methods: Between 2005 and 2011, 12 patients from Kyushu University Hospital had cervical adenocarcinoma, with a tumor depth of less than 3 mm and a horizontal width of less than 7 mm (FIGO stage IA1), diagnosed by cervical conization. All patients underwent simple hysterectomy or simple trachelectomy with pelvic lymphadenectomy. Results: The mean patient age was 34 years (range, 26-70 years). The median follow-up period was 70.5 months (range, 26-99 months). No pelvic lymph-node metastasis was seen, and no patient experienced disease recurrence. Conclusion: Early invasive cervical adenocarcinoma with a depth of invasion of 3 mm or less and a horizontal spread of 7 mm or less has little potential for nodal metastasis or recurrence. Therefore, simple hysterectomy or trachelectomy without lymphadenectomy is an important treatment options for stage IA1 cervical adenocarcinoma..
11. Hideaki Yahata, Hiroaki Kobayashi, Kenzo Sonoda, Mototsugu Shimokawa, Tatsuhiro Ohgami, Toshiaki Saito, Shinji Ogawa, Kunihiro Sakai, Akimasa Ichinoe, Yousuke Ueoka, Yasuyuki Hasuo, Makoto Nishida, Satohiro Masuda, Kiyoko Kato, Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclit, International Journal of Clinical Oncology, 2015.11.
12. H Yahata, M Saito, T Sendo, Y Itoh, M Uchida, T Hirakawa, H Nakano, R Oishi, Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer, Int. J. Cancer, 118, 2636-2638(2006), 2006.02.
13. Hideaki Yahata, Hiroaki Kobayashi, Toshiharu Kamura, Toshio Hirakawa, Kimitoshi Kohno, Michihiko Kuwano, Hitoo Nakano, Increased nuclear localization of transcription factor YB-1 in acquired cisplatin resistant ovarian cancer., J Cancer Res Clin Oncol, 2002.06.
Presentations
 Show All Presentations >>
1. Yahata Hideaki, International exchange for MIGS training：from Japan to Thailand, 第74回日本産科婦人科学会, 2022.08.
2. Hideaki Yahata, Prognostic Outcome and Complications of Sentinel Lymph Node Navigation Surgery for Early-Stage Cervical Cancer, 第55回日本癌治療学会, 2018.10.
3. Hideaki Yahata, Sentinel Node Navigation Surgery in Cervical Cancer, 25th Asian and Oceanic Congress of Obstetrics and Gynaecology , 2017.06.
4. Hideaki Yahata, Aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy: a multicenter, placebo-controlled, double-blind, randomized study in Japanese gynecologic patients receiving paclitaxel and carboplatin., Europian Society for Medical Oncology 2014, 2014.09.
5. 矢幡 秀昭, Our surgical form and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO 1A1), the 3rd Asian Society of Gynecologic Oncology, 2013.12.
Educational
Educational Activities
Gynecologic benign tumor
Gynecologica malignant tumor


Unauthorized reprint of the contents of this database is prohibited.

Copyright © 2006, Kyushu University. All rights reserved.